Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:909-915
Published online before print February 19, 2007, doi: 10.1161/01.HYP.0000259668.37901.8c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/4/909    most recent
01.HYP.0000259668.37901.8cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kusaba, K.
Right arrow Articles by Imaizumi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kusaba, K.
Right arrow Articles by Imaizumi, T.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Pathophysiology
Right arrow Cell signalling/signal transduction
Right arrow Other arteriosclerosis
Right arrow Growth factors/cytokines
Right arrow Gene therapy

(Hypertension. 2007;49:909.)
© 2007 American Heart Association, Inc.


Original Articles

Inhibition of Intrinsic Interferon-{gamma} Function Prevents Neointima Formation After Balloon Injury

Ken Kusaba; Hisashi Kai; Mitsuhisa Koga; Narimasa Takayama; Ayami Ikeda; Hideo Yasukawa; Yukihiko Seki; Kensuke Egashira; Tsutomu Imaizumi

From the Department of Internal Medicine (K.K., H.K., M.K., N.T., A.I., Y.S., T.I.), Division of Cardio-vascular Medicine, Kurume University School of Medicine, Kurume, Japan; the Department of Pharmaceutical Care and Health Sciences (M.K.), Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan; the Cardiovascular Research Institute (H.Y.), Kurume University, Kurume, Japan; and the Department of Cardiovascular Medicine (K.E.), Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

Correspondence to Hisashi Kai, Department of Internal Medicine, Division of Cardio-vascular Medicine, Kurume University School of Medicine, 67 Asahimachi, Kurume 830-0011, Japan. E-mail naikai{at}med.kurume-u.ac.jp

It is still controversial whether intrinsic interferon (IFN)-{gamma} promotes or attenuates vascular remodeling in hyperproliferative vascular disorders, such as neointima formation after balloon injury. Thus, we investigated whether inhibition of intrinsic IFN-{gamma} function prevents neointima formation. For this purpose, naked DNA plasmid encoding a soluble mutant of IFN-{gamma} receptor {alpha}-subunit (sIFN{gamma}R; an IFN-{gamma} inhibitory protein) or mock plasmid was injected into the thigh muscle of male Wistar rats 2 days before balloon injury (day –2). sIFN{gamma}R gene transfer significantly elevated serum levels of sIFN{gamma}R protein for 2 weeks. In mock-treated rats, balloon injury induced smooth muscle cell proliferation in the neointima with a peak at day 7 and produced thick neointima at day 14. sIFN{gamma}R treatment reduced the number of proliferating intimal smooth muscle cells by 50% at day 7 and attenuated neointima formation with a 45% reduction of the intima/media area ratio at day 14. In mock-treated rats, at day 7, balloon injury induced phosphorylation of signal transducer and activator of transcription-1 and upregulations of IFN regulatory factor-1 (a transcription factor mediating IFN-{gamma} signal). Balloon injury also upregulated the key molecules of neointima formation, such as intercellular adhesion molecule-1 and platelet-derived growth factor ß-receptor. These changes were suppressed by sIFN{gamma}R treatment. In conclusion, it is suggested that intrinsic IFN-{gamma} promotes neointima formation probably through IFN regulatory factor-1/intercellular adhesion molecule-1–mediated and platelet-derived growth factor–mediated mechanisms. Thus, inhibition of IFN-{gamma} signaling may be a new therapeutic target for prevention of neointima formation of hyperproliferative vascular disorders.


Key Words: IFN-{gamma} • neointima • gene therapy • inflammation • signaling




This article has been cited by other articles:


Home page
HypertensionHome page
H. Kudo, H. Kai, H. Kajimoto, M. Koga, N. Takayama, T. Mori, A. Ikeda, S. Yasuoka, T. Anegawa, H. Mifune, et al.
Exaggerated Blood Pressure Variability Superimposed on Hypertension Aggravates Cardiac Remodeling in Rats via Angiotensin II System-Mediated Chronic Inflammation
Hypertension, October 1, 2009; 54(4): 832 - 838.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. S. Fleenor and D. K. Bowles
Exercise training decreases the size and alters the composition of the neointima in a porcine model of percutaneous transluminal coronary angioplasty (PTCA)
J Appl Physiol, September 1, 2009; 107(3): 937 - 945.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Murayama, M. Takahashi, M. Takamoto, Y. Shiba, H. Ise, J. Koyama, Y.-i. Tagawa, Y. Iwakura, and U. Ikeda
Deficiency of tumour necrosis factor-{alpha} and interferon-{gamma} in bone marrow cells synergistically inhibits neointimal formation following vascular injury
Cardiovasc Res, November 1, 2008; 80(2): 175 - 180.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Gotsman and A. H. Lichtman
Targeting Interferon-{gamma} to Treat Atherosclerosis
Circ. Res., August 17, 2007; 101(4): 333 - 334.
[Full Text] [PDF]